UPDATE: Stifel Nicolaus Upgrades WebMD Health Corp to Buy Following Q4 Beat

Stifel Nicolaus upgraded WebMD Health Corp

from Hold to Buy and announced a $26.00 price target. Stifel Nicolaus commented, "We are upgrading shares of WebMD to Buy from Hold and establishing a $26 12-month price target, which is approximately 12.0x our 2014 adjusted EBITDA estimate of $90.2 million. We believe that pricing changes (greater choice and simplicity) implemented in 4Q12 suggest advertising trends are likely to improve. We expect traction in mobile to continue and provide a catalyst for a turnaround at WebMD." WebMD Health Corp closed at $16.30 on Thursday.